EyePoint Pharmaceuticals Inc (EYPT)
16.16
-0.31
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
16.16
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Gross Profit (TTM): 41.39M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 41.39M |
September 30, 2023 | 35.48M |
June 30, 2023 | 30.09M |
March 31, 2023 | 32.60M |
December 31, 2022 | 33.08M |
September 30, 2022 | 34.47M |
June 30, 2022 | 33.09M |
March 31, 2022 | 30.35M |
December 31, 2021 | 28.76M |
September 30, 2021 | 24.92M |
June 30, 2021 | 31.50M |
March 31, 2021 | 28.04M |
December 31, 2020 | 28.61M |
September 30, 2020 | 31.25M |
June 30, 2020 | 19.62M |
March 31, 2020 | 22.50M |
December 31, 2019 | 17.68M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
17.68M
Minimum
Dec 2019
41.39M
Maximum
Dec 2023
29.61M
Average
30.35M
Median
Mar 2022
Gross Profit (TTM) Benchmarks
INVO Bioscience Inc | 1.225M |
Bio-Path Holdings Inc | -- |
Ocular Therapeutix Inc | 53.16M |
Aileron Therapeutics Inc | -- |
Apellis Pharmaceuticals Inc | 338.08M |